Ovugel is a drug owned by AURORA PHARMACEUTICAL, INC. It is protected by 9 US drug patents filed from 2017 to 2030. Out of these, 3 patents are active and 6 patents have expired. Details of Ovugel’s patents and their expiration are given below.
Exclusivity Information
Ovugel holds 1 exclusivity out of which 1 has expired. Details of Ovugel's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Sep 18, 2017 |
About Ovugel
Ovugel is a drug
owned by AURORA PHARMACEUTICAL, INC.
Ovugel uses
Triptorelin Acetate as the active
ingredient.
Active Ingredient:
Ovugel uses
Triptorelin Acetate as the active ingredient.
Check out other Drugs and Companies using
Triptorelin Acetate ingredient.